Los neutrones rápidos en la radioterapia.

A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy.

Oral oncology·2006

Proton beam therapy and iris neovascularisation in uveal melanoma.

Eye (London, England)·2005

Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection.

Oral oncology·2000

Early closure of a randomized trial: surgery and postoperative radiotherapy versus radiotherapy in the management of intra-oral tumours.

Clinical oncology (Royal College of Radiologists (Great Britain))·1998

Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma.

The British journal of ophthalmology·1998

The treatment of recurrence following fast neutron therapy for head and neck malignancy.

Clinical otolaryngology and allied sciences·1996

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Electron nuclear dynamics of H+ + uracil at ELab = 1.47 and 4.00 keV: a prototype of ion cancer therapy reactions.

Physical chemistry chemical physics : PCCP·2026

Prone versus supine radiotherapy for right-sided breast cancer - a retrospective study of radiotherapy plans.

Radiation oncology (London, England)·2026

Dosimetric superiority of proton radiosurgery in liver cancer: an in silico comparative dosimetric study.

BMC cancer·2026

Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac.

European journal of nuclear medicine and molecular imaging·2026

Accelerated Partial Breast Irradiation Delivered with Helical Tomotherapy: Dosimetry and Volumetric Predictors of Ipsilateral Breast Dose.

Cancers·2026

Measuring reaction-in-flight neutrons via the activation technique.

The Review of scientific instruments·2026

Videos de Experimentos Relacionados

Los neutrones rápidos en la radioterapia.

Videos de Conceptos Relacionados

A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy.

Proton beam therapy and iris neovascularisation in uveal melanoma.

Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection.

Early closure of a randomized trial: surgery and postoperative radiotherapy versus radiotherapy in the management of intra-oral tumours.

Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma.

The treatment of recurrence following fast neutron therapy for head and neck malignancy.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Electron nuclear dynamics of H<sup>+</sup> + uracil at <i>E</i><sub>Lab</sub> = 1.47 and 4.00 keV: a prototype of ion cancer therapy reactions.

Prone versus supine radiotherapy for right-sided breast cancer - a retrospective study of radiotherapy plans.

Dosimetric superiority of proton radiosurgery in liver cancer: an in silico comparative dosimetric study.

Predicting tumour and organ dose in α-radiopharmaceutical therapy: a <sup>89</sup>Zr-based dosimetric approach for <sup>225</sup>Ac.

Accelerated Partial Breast Irradiation Delivered with Helical Tomotherapy: Dosimetry and Volumetric Predictors of Ipsilateral Breast Dose.

Measuring reaction-in-flight neutrons via the activation technique.

Videos de Experimentos Relacionados

Los neutrones rápidos en la radioterapia.

Videos de Conceptos Relacionados

Artículos Relacionados